BWP
GILD icon

BSW Wealth Partners’s Gilead Sciences GILD Stock Holding History

BSW Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$793K Sell
6,275
-18
-0.3% -$2.37K 0.09% 129
2026
Q1 		$877K Sell
6,293
-4,561
-42% -$639K 0.11% 110
2025
Q4 		$1.33M Sell
10,854
-19
-0.2% -$2.31K 0.16% 77
2025
Q3 		$1.21M Buy
10,873
+7,049
+184% +$801K 0.15% 75
2025
Q2 		$424K Buy
3,824
+12
+0.3% +$1.28K 0.06% 190
2025
Q1 		$427K Sell
3,812
-2,236
-37% -$231K 0.06% 180
2024
Q4 		$559K Buy
6,048
+335
+6% +$30.2K 0.08% 144
2024
Q3 		$479K Buy
5,713
+594
+12% +$45.3K 0.07% 163
2024
Q2 		$351K Buy
5,119
+324
+7% +$21.6K 0.06% 185
2024
Q1 		$351K Sell
4,795
-597
-11% -$45.9K 0.06% 192
2023
Q4 		$437K Sell
5,392
-453
-8% -$35.3K 0.09% 139
2023
Q3 		$438K Sell
5,845
-462
-7% -$35.5K 0.1% 123
2023
Q2 		$486K Sell
6,307
-308
-5% -$24.6K 0.1% 113
2023
Q1 		$549K Buy
6,615
+296
+5% +$24.5K 0.11% 125
2022
Q4 		$542K Buy
6,319
+835
+15% +$66.1K 0.12% 126
2022
Q3 		$338K Buy
5,484
+129
+2% +$8.13K 0.08% 156
2022
Q2 		$331K Buy
5,355
+36
+0.7% +$2.23K 0.08% 174
2022
Q1 		$316K Sell
5,319
-2,306
-30% -$147K 0.08% 198
2021
Q4 		$554K Buy
7,625
+2,638
+53% +$182K 0.14% 104
2021
Q3 		$348K Buy
4,987
+162
+3% +$11.4K 0.1% 149
2021
Q2 		$332K Buy
4,825
+1,015
+27% +$67.8K 0.09% 157
2021
Q1 		$246K Buy
+3,810
New +$246K 0.07% 180
2019
Q4 		– Sell
-1,327
Closed -$84K – 141
2019
Q3 		$84K Buy
1,327
+52
+4% +$3.4K 0.03% 115
2019
Q2 		$86K Buy
+1,275
New +$83.9K 0.03% 111

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BSW Wealth Partners's GILD Position: Q2 2026 in Review

BSW Wealth Partners reduced its Gilead Sciences (GILD) stake by 0.29% in Q2 2026, selling an estimated $2.37K and leaving 6,275 shares worth $793K. The position accounts for 0.09% of the portfolio, ranked #129.

BSW Wealth Partners first reported a position in GILD in Q2 2019 and has held it in 24 quarters since. The position peaked at $1.33M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BSW Wealth Partners held 6,275 shares of Gilead Sciences worth $793K as of Q2 2026.
  • BSW Wealth Partners sold 18 Gilead Sciences shares in Q2 2026, an estimated $2.37K.
  • Gilead Sciences made up 0.09% of BSW Wealth Partners's portfolio in Q2 2026, its #129 holding.
  • BSW Wealth Partners first reported a position in Gilead Sciences in Q2 2019 and has held it in 24 quarters since.
  • BSW Wealth Partners's Gilead Sciences position peaked at $1.33M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BSW Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.